Science

Apr 9, 2025, 10:38

Myeloma Paper of the Day, April 9th, suggested by Robert Orlowski

Robert Orlowski, Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:

“Myeloma Paper of the Day: Real-World International Staging System for newly diagnosed myeloma patients includes age >70 years (2 points), performance status >1 (2), PS 1 (1), t(14;16) (1), ISS III (1), ISS II (0.5), high LDH (0.5), and del(17p) (0.5).”

“A Real-World International Staging System (RW-ISS) for patients with newly diagnosed multiple myeloma”

Authors: Christian Brieghel, Tobias Schmidt Slørdahl, Morten Nørgaard Andersen, Agoston Gyula Szabo, Carsten Utoft Niemann and Sigrún Thorsteinsdóttir.

More posts featuring Robert Orlowski.

Agoston Gyula Szabo cancer Carsten Utoft Niemann and Sigrún Thorsteinsdóttir Christian Brieghel Morten Nørgaard Andersen multiple myeloma Myeloma Paper of the Day OncoDaily Oncology Real-World International Staging System Robert Orlowski RW-ISS Tobias Schmidt Slørdahl

FDA Approves Nivolumab and Ipilimumab for First-Line Treatment of Unresectable Hepatocellular Carcinoma Based on CheckMate-9DW Trial

John Cena Announces He Overcame Skin Cancer Twice, Advocates for Sun Safety

William N. Hait to Receive 2025 AACR-Margaret Foti Award for Leadership in Cancer Research

Stella Kyriakides joins ESO as Co-Chair and Senior Lecturer in Cancer Policy to Guide the 2026–2028 Strategic Plan

FDA Approves Nivolumab and Ipilimumab for Unresectable or Metastatic MSI-H or dMMR Colorectal Cancer: CheckMate 8HW trial results